News
Study protocol: Phase 2 trial of re-treatment with 177Lu-PSMA-617 molecular radiotherapy for metastatic castration resistant prostate cancer (RE-LuPSMA trial). Previously presented at ESMO 2024, FPN: ...
Phase 2 cohort-2 trial in progress: Vabametkib plus lazertinib for patients with EGFR-mutant NSCLC who developed resistance to 1st-line, 3rd-gen-EGFR TKIs via C-Met dysregulation. A randomized phase 3 ...
Additionally, the application says it may provide 'human specimen/medical lab testing in the future.' The lab would operate out of the ground floor of the former U.S. Renal Care Dialysis Center ...
Grad staff, fellow and resident assistants are exempt (salaried) positions paid biweekly.* Approvals are due by 10 p.m. on Mondays following the end of the pay period. A best practice for most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results